Startup Cellares adds $255M as investors pour cash into cell therapy production
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Elevate Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.
This article is the final installment of a three-part series examining how advanced therapy scientific and quality expectations are impacting...
Five biopharmaceutical manufacturing execs share the trends and innovations they are paying closest attention to and why.